OHIP Bulletin – COVID-19 Advance Payment Program

Please find information on this program here: OHIP Bulletin – Advance Payment Program […]

Read More…


Delayed Payments For Virtual Care – How This Impacts Recently Graduated Rheumatologists

Delayed Funding for Virtual Care Puts New Rheumatologists at Risk of Closure, Affecting Patient Care During COVID-19 Every Ontarian has been affected by COVID-19, including recently graduated rheumatologists. New rheumatologists have stepped-up to […]

Read More…


ORA Official Position Statement – Funding for Virtual Care During COVID-19

The ORA has published an official position statement on this topic: Position on OHIP Funding We also draw your attention to the OMA’s Protect Healthcare initiative #DotheRightThing […]

Read More…


We Are Providing Excellent Virtual Care to Our Patients During COVID-19. We Need Your Support to Continue Looking After You!

A Message from the ORA President, Dr. Jane Purvis Re: Doctors against Covid #DoTheRightThing When social distancing measures were implemented last month, the rheumatology community quickly adapted in order to provide virtual care […]

Read More…


DO NOT SUBMIT VIRTUAL CODES YET

Please do not submit any of the new virtual care billing codes including K083 until directed by the OMA and the Ministry that this code can be accepted by OHIP computers. There has […]

Read More…


OTN – OneID Registration Instructions

At the April 7, ORA Virtual Town Hall, Janet Gallant from OTN was able to answer many of your questions, including how to sign up!  We are pleased to share the following instructions […]

Read More…


New Rituximab Biosimilar Now Available! + Actemra Auto Injector & Pre-filled Syringe Approved by EAP!

Effective today, March 31, Truxima (rituximab) has new LU codes for RA. Here is the information shared by the Ministry: Truxima (rituximab) 100mg/10mL, 500mg/50mL – Inj Sol (CEH) LU Code 575 For the […]

Read More…


Information on Providing Care during the COVID-19 pandemic

Published March 6, 2020.  Last updated March 25, 2020  1:45PM This section originally contained information on providing virtual care for your patients.  Given the rapidly changing situation with COVID-19 we have expanded to […]

Read More…


ORA Supports the OMA Policy on Distancing and Statement on Use of Hydroxychloroquine for COVID-19

The ORA offers its support of the new revised OMA policy on Physical Distancing.  In particular we support the revised guidance for “Physical Distancing and Social Isolation” which makes even more explicit the […]

Read More…


EAP Renewals Automatically Extended for 90 Days

Good news! We have heard from David Schachow, Director, Drug Programs Delivery Branch, that the Ontario Public Drug Programs is authorizing the automatic extension of all EAP approvals with a funding date that […]

Read More…